MedStar Health performs new incision-free treatment for fibroids

MedStar Health at Lafayette Centre is the first in the Maryland, Virginia, and Washington, D.C. region to perform the Sonata treatment

December 10, 2020

Washington, D.C. – MedStar Health at Lafayette Centre has become the first in the Maryland, Virginia, and Washington, D.C. region to perform a new advanced gynecologic treatment for women with symptomatic uterine fibroids. The new treatment is called Sonata and uses no incisions. It gives women a fast recovery with excellent reduction in heavy menstrual bleeding caused by fibroids and provides an option to avoid invasive surgery.

Dr. Vadim Morozov standing next to the Sonata System“As an investigator in the original Sonata FDA clinical trial, I was very impressed by the results of the study and the positive impact Sonata had on women’s lives,” said Vadim Morozov, MD, a minimally invasive gynecological surgeon for MedStar Health who performed the first Sonata treatment at MedStar Health at Lafayette Centre for a Maryland woman on November 30.

“Sonata is an alternative to hysterectomy and myomectomy and can treat a wide range of fibroid types, sizes, and locations,” said Dr. Morozov. 

Fibroids are benign growths in or around the uterus, with about 70 percent of white women and more than 80 percent of black women having uterine fibroids before the age of 50. 

The Sonata System uses a unique intrauterine ultrasound handpiece to locate and target the individual fibroids. Radiofrequency energy is then delivered to shrink the fibroid and reduce symptoms of bleeding. The fibroids are treated from inside the uterus and requires no incisions to the abdomen, no tissue is surgically removed, and the uterus is preserved. 

Clinical studies with Sonata demonstrate that nearly 90 percent of women showed a reduction in menstrual bleeding three months after the procedure and 95 percent had a reduction in bleeding after 12 months.  Additionally, more than 50 percent of women returned to normal activities the next day.

Uterine fibroids may cause significant and debilitating symptoms, including heavy menstrual bleeding.  Symptoms may worsen over time if fibroids are left untreated, which leads to more than two million women in the U.S. undergoing treatment for uterine fibroids each year.

For more information on the Sonata Treatment and to watch patient testimonials, please visit www.sonatatreatment.com.

Media Contact

Marianne Worley
410-772-6661
[email protected]